Skip to main content
. 2016 May 6;53(9):608–615. doi: 10.1136/jmedgenet-2016-103832

Table 1.

Clinical, neuroimaging and genetic features of children with JS having CEP120 mutations

Family COR391 MTI-143 MTI-991 MTI-1516
Affected individuals (sex) 1 (F) 1 (M) 1 (M) 1 (F)
Age at last examination 4 years+7 months 11 years 2 years+1 month 2 years
Consanguinity Yes No Yes No
Country of origin Italy USA Palestine India
Nucleotide change c.581T>C hom c.2177T>C/c.2134C>T c.(49+5_49+10del; 49+5_49+ 10delins477) hom c.1138_1139insA/c.1646C>T
Protein change p.Val194Ala hom p. Leu726Pro/p.Leu712Phe p.(Gly+1Aspfs*14;?) p.Ser380Thrfs*19/p.Ala549Val
LOVD screening ID 00058830 00058831 00058832 00058833
LOVD individual ID 0000058794 0000058793 0000058796 0000058797
Neurological signs
 Hypotonia Yes Yes Yes Yes
 Developmental delay/cognitive impairment Yes Yes Yes Yes
 Abnormal breathing No Yes No Yes
 Abnormal ocular movements No OMA, nystagmus, Duane syndrome No Strabismus
 Truncal ataxia Yes No Yes No
Other organ involvement
 Retinal No No No No
 Renal No No* No No
 Hepatic No No No No
 Oral-facial No No No No
 Skeletal No No No No
Neuroimaging
 Molar tooth sign Yes Yes Yes Yes
 Other Mild ventriculomegaly CC hypoplasia No No

*Grade II-III hydronephrosis was detected at birth but it spontaneously resolved after few months. No renal problems have been reported since then.

CC, corpus callosum; F, female; JS, Joubert syndrome; LOVD, Leiden Open (source) Variation Database; M, male; OMA, ocular motor apraxia.